MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid-beta (Aβ) peptides and neurofibrillary tangles (NFTs) induced by the hyperphosphorylation of tau proteins [1].